Legal Status of Peptides in Australia (2026)
Research peptides are legal to purchase in Australia for scientific and laboratory research. The Therapeutic Goods Act 1989 defines therapeutic goods as substances represented or used for therapeutic use. Products sold strictly for research — not represented as therapeutic goods — fall outside the Act's scheduling framework.
The Therapeutic Goods Administration (TGA) regulates medicines and medical devices in Australia. Research peptides such as BPC-157, TB-500, CJC-1295, Ipamorelin, GHK-Cu, Glutathione, and NAD+ are not listed on the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP) in a way that prohibits research imports. The TGA's enforcement focus is on therapeutic marketing claims — ORYN makes none.
TGA Research-Use Position and ABF Clearance
The Australian Border Force (ABF) handles import clearance. Research peptides imported from the EU with proper research-use labelling, a Certificate of Analysis, and a commercial invoice clearing the contents as "research chemicals — not for human consumption" pass through ABF when dispatched via DHL Express with pre-cleared paperwork.
Compliance points: - Every pen and carton labelled "for research purposes only" - No therapeutic, medical, or dosing guidance provided - COA from an accredited laboratory included - GMP manufacturing with independent HPLC purity verification (>99%)
AVAILABLE PEPTIDE PENS
Delivery to Australia — DHL Express duty-paid
ORYN delivers peptide pens across Australia in 7–10 business days via DHL Express International. Sydney, Melbourne, Brisbane, Perth, Adelaide, Canberra, and Hobart typically receive orders in 7–8 business days; Northern Territory, rural Western Australia, and Tasmania add 1–2 days.
Delivery details: - Duty- and GST-paid DHL Express International - Cold-chain insulated packaging - Discreet outer packaging - COA and research-use declaration enclosed - End-to-end tracking